FAA Waiver Lets Boeing Sell 35 More 777F Freighters After 2028

What happened

The FAA approved a waiver of aircraft emissions rules, permitting Boeing to sell an additional 35 777F freighters after 2028. This regulatory relief extends the life of the 777F program beyond the previous regulatory deadline, providing Boeing with more flexibility to convert potential freighter demand into orders. However, the waiver is narrowly scoped to the 777F and does not address the more critical FAA-controlled constraints on 737 production rates or the pending certifications of the 737 MAX 7 and MAX 10. Boeing's investment case remains centered on whether it can increase 737 deliveries from 47 to 52 per month and achieve the MAX 7/MAX 10 certifications in 2026, as these drive the bulk of cash flow and inventory monetization. Therefore, while the news is incrementally positive for the 777F program, it does not materially alter the core thesis that Boeing's valuation is still hostage to regulator-controlled milestones.

Implication

The FAA's waiver regarding 777F sales is a limited regulatory concession that does not change the fundamental operational challenges facing Boeing. The 35 additional 777F sales, if realized, would contribute to revenue and cash flow but are small relative to the overall commercial backlog and the financial impact of 737/787 production constraints. The key catalysts remain the FAA production certification for the new 737 North Line and the formal certifications of the 737-7 and 737-10, which are necessary for Boeing to monetize stored inventory and increase deliveries. Without progress on these milestones, Boeing's valuation at 30x EV/EBITDA and 87x P/E lacks margin of safety, and the stock is unlikely to re-rate significantly based on this news alone. Therefore, investors should continue to monitor the FAA-driven milestones and avoid reading this waiver as a signal that regulatory headwinds are easing broadly.

Thesis delta

The news introduces no shift to the investment thesis. It is a positive but immaterial regulatory development that does not change the core risk-reward calculus. The thesis remains WAIT, contingent on FAA certification of 737 production expansion and MAX variants.